1181 related articles for article (PubMed ID: 25449570)
1. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
2. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
3. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
4. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
5. The Prion Concept and Synthetic Prions.
Legname G; Moda F
Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
7. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
8. Protein folding and aggregation: two sides of the same coin in the condensation of proteins revealed by pressure studies.
Silva JL; Cordeiro Y; Foguel D
Biochim Biophys Acta; 2006 Mar; 1764(3):443-51. PubMed ID: 16480935
[TBL] [Abstract][Full Text] [Related]
9. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.
Victoria GS; Zurzolo C
Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281
[TBL] [Abstract][Full Text] [Related]
10. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Prion Amplification Methodology for Inhibitor Screening.
Vieira TCRG; Silva JL
Methods Mol Biol; 2019; 1873():305-316. PubMed ID: 30341619
[TBL] [Abstract][Full Text] [Related]
12. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
13. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
Jeffrey M
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
15. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
16. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
17. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
18. The structure of prion: is it enough for interpreting the diverse phenotypes of prion diseases?
Tian C; Dong X
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):429-34. PubMed ID: 23459557
[TBL] [Abstract][Full Text] [Related]
19. Prion protein oligomer and its neurotoxicity.
Huang P; Lian F; Wen Y; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
[TBL] [Abstract][Full Text] [Related]
20. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
